Recombinant NV-A01 adenovirus

N/A

Report date: 2025/02/26 15:15:31

Base Information

Drug NameRecombinant NV-A01 adenovirus
Drug Alias Name重组NV-A01腺病毒注射液
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionApolipoprotein A-I modulators
TargetsApolipoprotein A-I
Therapy Area/IndicationsSolid tumoursGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Nuowei Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesFirst Affiliated Hospital Of Wannan Medical CollegeNanjing Nuowei Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A